Literature DB >> 10668953

Relationship between some prognostic markers of HD patients and serum erythropoietin, insulin-like growth factor-1, leptin, parathormone and testosterone.

M Majdan1, J Kotarski, A Ksiaźek, A Grzebalska.   

Abstract

Iseki et al. [1] have shown that serum levels of albumin (Alb), creatinine (Cr) and BMI are significant predictors of death in haemodialyzed patients (HD pts). In our study we decided to assess the relationship between the levels of Alb, Cr, BMI and substances which have a known metabolic effect on nutritional status in HD pts: endogenous erythropoietin (Epo), insulin-like growth factor-1 (IGF-1), leptin (Lep), parathormone (PTH), and testosterone. The study was conducted in 53 (28M, 25F) stable HD pts. Serum levels of endogenous Epo and PTH were estimated by CLIA; IGF-1, Lep, testosterone, sex hormone binding globulin were estimated by RIA. The multiple regression analysis was done between Alb, Cr, BMI and Epo, IGF-1, PTH and Lep for all HD pts together and free androgen index (FAI) for men and women separately. Correlations: the level of serum albumin did not correlate significantly with any of the measured substances. Serum creatinine level significantly correlated only with the level of IGF-1 (p=0.02), BMI was significantly correlated with serum endogenous Epo (p<0.01), leptin (p=0.004) and FAI (p<0.005) both in men and women. We concluded that the higher concentrations of endogenous Epo, IGF-1 and testosterone could be correlated with a better prognosis in HD patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668953     DOI: 10.1023/a:1007135916582

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

Review 1.  Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure.

Authors:  A J Erslev; A Besarab
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

2.  Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study.

Authors:  J L Teruel; R Marcén; J F Navarro; J J Villafruela; M Fernández Lucas; F Liaño; J Ortuño
Journal:  Nephron       Date:  1995       Impact factor: 2.847

3.  Assessment of nutritional status in CAPD patients: serum albumin is not a useful measure.

Authors:  C H Jones; C G Newstead; E J Will; S W Smye; A M Davison
Journal:  Nephrol Dial Transplant       Date:  1997-07       Impact factor: 5.992

4.  Mechanisms of malnutrition in uremia.

Authors:  G Guarnieri; G Toigo; N Fiotti; B Ciocchi; R Situlin; C Giansante; A Vasile; M Carraro; L Faccini; G Biolo
Journal:  Kidney Int Suppl       Date:  1997-11       Impact factor: 10.545

5.  Malnutrition as the main factor in morbidity and mortality of hemodialysis patients.

Authors:  S R Acchiardo; L W Moore; P A Latour
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

6.  Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients.

Authors:  F Kokot; A Wiecek; J Mesjasz; M Adamczak; U Spiechowicz
Journal:  Nephrol Dial Transplant       Date:  1998-05       Impact factor: 5.992

7.  IGF-I, a marker of undernutrition in hemodialysis patients.

Authors:  V Jacob; J E Le Carpentier; S Salzano; V Naylor; G Wild; C B Brown; A M el Nahas
Journal:  Am J Clin Nutr       Date:  1990-07       Impact factor: 7.045

8.  Serum albumin is a strong predictor of death in chronic dialysis patients.

Authors:  K Iseki; N Kawazoe; K Fukiyama
Journal:  Kidney Int       Date:  1993-07       Impact factor: 10.612

9.  IGF-I as an early indicator of malnutrition in patients with end-stage renal disease.

Authors:  T Sanaka; M Shinobe; M Ando; N Hizuka; H Kawaguchi; H Nihei
Journal:  Nephron       Date:  1994       Impact factor: 2.847

10.  Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy.

Authors:  F Kokot; A Wiecek; H Schmidt-Gayk; W Marcinkowski; U Gilge; A Heidland; R Rudka; J Trembecki
Journal:  Artif Organs       Date:  1995-05       Impact factor: 3.094

View more
  2 in total

1.  Skeletal effects of erythropoietin in hemodialysis patients.

Authors:  Tsuneo Takenaka; Yoshiaki Itaya; Ichiro Ishikawa; Kenji Kobayashi; Yoshitsugu Tsuchiya
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

2.  A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients.

Authors:  Ahmad Majzoub; Daniel A Shoskes
Journal:  Transl Androl Urol       Date:  2016-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.